The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Hohl Benjamin

Reporting owner CIK 0001882764 · CHIEF FINANCIAL OFFICER

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Hohl BenjaminHohl BenjaminHohl Benjamin · October 19, 2026 · Exercise / conversion · Common StockHohl Benjamin · December 22, 2025 · Exercise / conversion · Common StockDec 22, 2025Oct 19, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

2 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 19, 2026Enliven Therapeutics, Inc.Common StockHohl BenjaminExercise / conversion
Dec 22, 2025Enliven Therapeutics, Inc.Common StockHohl BenjaminExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Enliven Therapeutics, Inc.ELVN · company listings
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon StockNon-derivative security · Code M6,01814.85Value: 89,367.3Currency not specifiedView ↗
Trade: Enliven Therapeutics, Inc.ELVN · company listings
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon StockNon-derivative security · Code M13,0002.48Value: 32,240Currency not specifiedView ↗